Spine Takes Yuhan’s Peptide Into US Phase III For High-Need DDD

Second Asset In Global Pivotal Trials

 
• By Jung Won Shin
back pain
Treatment Aims To Change Standard Of Care For CLBP patients • Source: Alamy

More from South Korea

More from Focus On Asia